
|Articles|September 1, 2004 (Updated: November 15, 2020)
- Pharmaceutical Executive-09-01-2004
September Table of Contents
September Table of Contents
Advertisement
Articles in this issue
over 21 years ago
September Table of Contentsover 21 years ago
(Huge) Untapped Opportunityover 21 years ago
Information Into Actionover 21 years ago
Halting the Hypeover 21 years ago
Spend Trends: A $20 Billion Bill and Plenty of Changeover 21 years ago
From the Mouths of Babesover 21 years ago
Safe and Secureover 21 years ago
Synta's Surpriseover 21 years ago
The New Building Blocks for Blockbustersover 21 years ago
Specialty Therapies Lose Special StatusNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5




